Tyrosine News and Research

RSS

Researchers discover new target for treating diseases linked to T-cell leukemia virus type 1

A team of researchers from Penn State College of Medicine found a new target for treating diseases associated with human T-cell leukemia virus type 1 (HTLV-1).

22 Jul 2024

Deciphering the role of RET in cancer and breakthroughs in targeted treatments

Xueqing Hu , Ujjwol Khatri , Tao Shen , and Jie Wu, at University of Oklahoma Health Sciences Center, USA, provides a comprehensive review of the role of the RET (REarranged during Transfection) receptor tyrosine kinase in cancer development and the advancements in RET-targeted cancer therapies.

19 Jul 2024

Chronic Urticaria: Addressing unmet needs, emerging therapies, and advances in personalized treatment approaches

Emerging personalized treatment approaches for chronic urticari.

16 Jul 2024

Study finds specific gut microbiota signature is associated with vulnerability to food addiction

Researchers of a recent study published in Gut explored gut microbial involvement in food addiction-related processes.

1 Jul 2024

Live biotherapeutic product can improve clinical outcomes for patients with kidney cancer

Physician scientists from City of Hope, one of the largest cancer research and treatment organizations in the United States, found that people with metastatic kidney cancer who orally took a live biotherapeutic product called CBM588 while in treatment with immunotherapy and enzymatic tyrosine kinase inhibitors experienced improved health outcomes.

28 Jun 2024

New Approach to Treating Melanoma

An international research team, led by Professor Wenbo Bu of Fudan University and Distinguished Professor Dayong Jin of the University of Technology Sydney, have discovered an innovative method to effectively treat cancer by reactivating suppressed metabolic pathways in cancer cells.

20 Jun 2024

New technique uses nutrients to effectively treat cancer

An international research team has discovered a new way to effectively treat cancer, by using nutrients to reactivate suppressed metabolic pathways in cancer cells.

17 Jun 2024

Study uncovers why targeted therapy fails in some non-small cell lung cancer patients

The reason why targeted treatment for non-small cell lung cancer fails to work for some patients, particularly those who have never smoked, has been discovered by researchers from UCL, the Francis Crick Institute and AstraZeneca.

13 Jun 2024

Researchers engineer water-soluble histidine kinase for enhanced antibiotic drug screens

A bacterial enzyme called histidine kinase is a promising target for new classes of antibiotics. However, it has been difficult to develop drugs that target this enzyme, because it is a "hydrophobic" protein that loses its structure once removed from its normal location in the cell membrane.

11 Jun 2024

Unveiling the epigenetic impact of prenatal amphetamine exposure using C. elegans models

Amphetamine is a psychostimulant that has been used to treat a variety of brain dysfunctions. However, it is a highly abused drug.

30 May 2024

Exercise-induced exerkines: Secret weapon in disease prevention and therapy

A recent review in Signal Transduction and Targeted Therapy highlights the role of exercise-induced molecules, exerkines, in disease prevention and treatment, emphasizing their molecular mechanisms and therapeutic potential.

29 May 2024

Targeting CD47 to improve osimertinib efficacy in EGFR mutant NSCLC

NSCLC is the leading cause of cancer deaths globally, with EGFR mutations being a common feature in these cancers.

28 May 2024

Study demonstrates causal link between microbial factors and dysfunction of ISCs in colitis

In a study published in Cell Host & Microbe, a research team led by Prof. PAN Wen from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences, in collaboration with research teams led by Prof. ZHU Shu and Prof. SONG Xinyang, demonstrated the causal link between microbial factors and dysfunction of intestinal stem cells (ISCs) in colitis.

23 May 2024

Study links gut microbiome modulation to changes in social behavior

Taking pro- and prebiotics could make people more sensitive to fairness, even at the cost of earning less money, according to a study.

15 May 2024

Enhancing the ability of natural killer cells to combat hematologic malignancies

A new study reveals a groundbreaking approach to immunotherapy, demonstrating that blocking the interaction between the CD300A receptor and phosphatidylserine (PS) significantly enhances the ability of human natural killer (NK) cells to lyse hematologic malignancies (HMs).

9 May 2024

Tyrosine News and Research

Researchers discover new target for treating diseases linked to T-cell leukemia virus type 1

Deciphering the role of RET in cancer and breakthroughs in targeted treatments

Chronic Urticaria: Addressing unmet needs, emerging therapies, and advances in personalized treatment approaches

Study finds specific gut microbiota signature is associated with vulnerability to food addiction

Live biotherapeutic product can improve clinical outcomes for patients with kidney cancer

New Approach to Treating Melanoma

New technique uses nutrients to effectively treat cancer

Study uncovers why targeted therapy fails in some non-small cell lung cancer patients

Researchers engineer water-soluble histidine kinase for enhanced antibiotic drug screens

Unveiling the epigenetic impact of prenatal amphetamine exposure using C. elegans models

Exercise-induced exerkines: Secret weapon in disease prevention and therapy

Targeting CD47 to improve osimertinib efficacy in EGFR mutant NSCLC

Study demonstrates causal link between microbial factors and dysfunction of ISCs in colitis

Study links gut microbiome modulation to changes in social behavior

Enhancing the ability of natural killer cells to combat hematologic malignancies

Father's gut health in mice linked to offspring's well-being, study finds

Aspirin shows no benefit in preventing breast cancer recurrence, study finds

Insilico Medicine's AI-driven approach yields promising PTPN2/N1 inhibitor for cancer immunotherapy

Rare variants in the YKT6 gene cause new neurological disorder, study finds

Focusing on oncogenic driver mutations and resistance mechanisms in the treatment of NSCLC

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Latest News